Author = F Golchinfar
Unleashing Monoclonal Antibodies: Targeting Covid-19’s Nucleocapsid Protein and Spike Antigens

Articles in Press, Accepted Manuscript, Available Online from 28 September 2024

10.22092/ari.2024.365665.3118

Rasool Madani; Fariba Golchinfar; Mahsa Hezarosi; Tara Emami; Arash Ghanizade


Development of an ELISA for SARS-CoV-2 Detection focusing on antibodies against nucleocapsid protein

Articles in Press, Accepted Manuscript, Available Online from 28 September 2024

10.22092/ari.2024.366081.3188

Fariba Golchinfar; Rasool Madani; Mahsa Hezarosi; Tara Emami; Arash Ghanizade


Preparation and Characterization of Nanoliposome Containing Isolated VP1 Protein of Foot and Mouth Disease Virus as a Model of Vaccine

Volume 77, Issue 1, January and February 2022, Pages 37-44

10.22092/ari.2021.353322.1596

M Kazemi; R Madani; M. R Aghamaali; T Emami; F Golchinfar; L Heshmati


Immunity Evaluation of an Experimental Designed Nanoliposomal Vaccine Containing FMDV Immunodominant Peptides

Volume 76, Issue 5, November and December 2021, Pages 1183-1190

10.22092/ari.2021.352498.1566

L Heshmati; S. M Rezayat; R Madani; T Emami; M. R Jafari; F Golchinfar; M Kazemi; S. M Azimi Dezfouli